Live Breaking News & Updates on Peter salzmann

Stay informed with the latest breaking news from Peter salzmann on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Peter salzmann and stay connected to the pulse of your community

Immunovant, Inc. (NASDAQ:IMVT) Expected to Post Q1 2026 Earnings of ($0.49) Per Share

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for Immunovant in a research note issued on Monday, April 8th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share of ($0.49) for the quarter, down from their […]

United-states , America , Eva-renee-barnett , Peter-salzmann , Immunovant-inc , Cantor-fitzgerald , Securities-exchange-commission , Immunovant-company-profile , Perceptive-advisors , Hermes-inc , Nasdaq , Zacks-research

Immunovant (NASDAQ:IMVT) Given Buy Rating at Truist Financial

Immunovant (NASDAQ:IMVT) Given Buy Rating at Truist Financial
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Juliag-butchko , Peter-salzmann , Wolfe-research , Vanguard-group-inc , Deutsche-bank-aktiengesellschaft , Blackrock-inc , Jpmorgan-chase-co , Immunovant-company-profile , Immunovant-inc , Securities-exchange-commission

Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Buy" by Analysts

Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Buy" by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Eva-renee-barnett , Peter-salzmann , Blackrock-inc , Nasdaq , Goldman-sachs-group , Immunovant-inc , Wolfe-research , Securities-exchange-commission , Vanguard-group-inc , Deutsche-bank-aktiengesellschaft

Immunovant, Inc. (NASDAQ:IMVT) Receives $47.88 Consensus Price Target from Brokerages

Immunovant, Inc. (NASDAQ:IMVT) Receives $47.88 Consensus Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Eva-renee-barnett , Peter-salzmann , Perceptive-advisors , Hermes-inc , Jpmorgan-chase-co , Immunovant-inc , Nasdaq , Goldman-sachs-group , Cantor-fitzgerald , Get-free-report , Stock-down , Renee-barnett

Immunovant (NASDAQ:IMVT) Given "Buy" Rating at Truist Financial

Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Truist Financial in a report issued on Monday, Benzinga reports. They presently have a $48.00 price target on the stock. Truist Financial’s price target indicates a potential upside of 47.28% from the stock’s previous close. A number of […]

Juliag-butchko , Peter-salzmann , Goldman-sachs-group , Wolfe-research , Principal-financial-group-inc , Cantor-fitzgerald , Immunovant-company-profile , Securities-exchange-commission , Nasdaq , Immunovant-inc , Investment-company-inc , Citigroup-inc

Immunovant (NASDAQ:IMVT) Stock Rating Reaffirmed by Truist Financial

Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Truist Financial in a report issued on Monday, Benzinga reports. They presently have a $48.00 price target on the stock. Truist Financial’s price objective indicates a potential upside of 47.28% from the stock’s previous close. Several other brokerages have […]

Florida , United-states , Peter-salzmann , Juliag-butchko , Deutsche-bank-aktiengesellschaft , Goldman-sachs-group , Wolfe-research , Immunovant-company-profile , Board-of-administration-florida-retirement-system , Securities-exchange-commission , Immunovant-inc , Jpmorgan-chase-co

Fred Alger Management LLC Raises Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)

Fred Alger Management LLC Raises Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Alger , Algeria , United-states , America , Eva-renee-barnett , Peter-salzmann , Holdings-channel , Deutsche-bank-aktiengesellschaft , Nasdaq , Securities-exchange-commission , Wolfe-research , Fred-alger-management

Fred Alger Management LLC Raises Stake in Immunovant, Inc. (NASDAQ:IMVT)

Fred Alger Management LLC Raises Stake in Immunovant, Inc. (NASDAQ:IMVT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Alger , Algeria , China , Peter-salzmann , Marks-levine , Jpmorgan-chase-co , Life-insurance-co , Barclays-plc , Immunovant-inc , Fred-alger-management , Wolfe-research , Nasdaq

Profund Advisors LLC Raises Stake in Immunovant, Inc. (NASDAQ:IMVT)

Profund Advisors LLC grew its stake in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 9.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 49,869 shares of the company’s stock after acquiring an additional 4,115 shares during the quarter. Profund Advisors […]

United-states , America , Peter-salzmann , Juliag-butchko , Immunovant-inc , Exchange-commission , Profund-advisors , Securities-exchange-commission , Connor-clark-lunn-investment-management-ltd , Immunovant-company-profile , Hermes-inc , Cantor-fitzgerald

Brokers Set Expectations for Immunovant, Inc.'s FY2028 Earnings (NASDAQ:IMVT)

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities research analysts at HC Wainwright raised their FY2028 earnings per share estimates for shares of Immunovant in a research note issued to investors on Tuesday, February 13th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of $2.16 for the year, […]

United-states , America , Peter-salzmann , Piper-sandler , Marks-levine , Nasdaq , Nuveen-asset-management , Wolfe-research , Weiss-multi-strategy-advisers , Blue-owl-capital-holdings , Immunovant-company-profile , Securities-exchange-commission